Clinical trial
A Post-Market Registry of the BioFreedomTM Biolimus A9TM Coated Coronary Stent System
NCT03745066 is registered in ClinicalTrials.gov with Biosensors Europe SA as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Post-Market Registry of the BioFreedomTM Biolimus A9TM Coated Coronary Stent System
- Lead sponsor
- Biosensors Europe SA
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- April 4, 2019
- Completion date
- April 27, 2022
- Enrollment
- 1,500 (estimated)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.